Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
635.00    6.00 (0.95%)
Bid:
636.00
Ask:
638.00
Spread: 2.00 (0.314%)
Market Cap: £513.35m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Appointment of Executive Director

15 Apr 2026 07:00

RNS Number : 4759A
Bloomsbury Publishing PLC
15 April 2026
 

 

BLOOMSBURY PUBLISHING PLC 

("Bloomsbury" or "the Company")

 

Bloomsbury strengthens Board with appointment of Jenny Ridout and streamlines structure

Bloomsbury is streamlining its operating structure and strengthening its Board for the next stage of growth. Jenny Ridout, currently Managing Director of the Academic & Professional Division, has been appointed to the Bloomsbury Board of Directors.

Bloomsbury Chairman, John Bason, said, "Jenny Ridout has been appointed as an Executive Director on the Board of Directors of Bloomsbury. This follows our long established practice of having the leader of our academic publishing on the board. Jenny has also been our leader in Artificial Intelligence and was instrumental in both the AI training deal we announced in July and the partnership with Google we announced in December. She recently studied for a Post Graduate Diploma in Artificial Intelligence for Business from the Saїd Business School in Oxford. The board welcomes her voice for the future."

Bloomsbury is also streamlining its operating structure, while retaining the current financial reporting. The company has operated a matrix structure with three major editorial divisions serviced by a global sales, marketing and publicity division. The central matrix structure has served Bloomsbury well over a period of considerable growth. To take this growth to the next stage, it has been decided to restructure to three vertical business units, with each business unit operating with its own editorial, sales, marketing and publicity, rights and audio functions reporting directly into the managing director of each. The new structure positions the company for greater agility, clearer accountability and continued expansion:

· Bloomsbury Global Academic & Professional led by Jenny Ridout;

· Bloomsbury USA led by Sabrina McCarthy, who continues to lead US Consumer and now also assumes responsibility for US A&P sales and marketing, rights and audio activity; and

· Bloomsbury Consumer UK led by Kathleen Farrar, who becomes Managing Director of Consumer UK. Ian Hudson is retiring from his full time role and will remain with the company as a consultant to contribute to longer term strategic planning.

Bloomsbury has consolidated central functions under Chief Finance & Operations Officer, Keith Underwood. These responsibilities will include Finance, Investor Relations, Commercial & Metadata, Operations, Royalties, Technology, Website and a central Project/Change Management office.

Nigel Newton, Chief Executive, said, "The new organisational structure creates a clearer, more agile framework that will enable us to deliver the next phase of Bloomsbury's growth. By aligning our business units more closely with our key markets, we can respond to changing tastes and customer preferences, strengthening our international and digital capabilities, and leverage new technologies. We are positioning the company to align with our ambitions, to take best advantage of the opportunities ahead and to continue to create long term success."

 

For further information, please contact:

Bloomsbury Publishing Plc

Tamsin Garrity, Group Investor Relations Director

tamsin.garrity@bloomsbury.com 

Hudson Sandler

Dan de Belder / Hattie Dreyfus / Emily Brooker

bloomsbury@hudsonsandler.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASFDFWLEMSEIL
Date   Source Headline
29th Jun 20265:06 pmRNSHolding(s) in Company
24th Jun 20265:08 pmRNSHolding(s) in Company
19th Jun 20264:11 pmRNSAnnual Financial Report
8th Jun 20263:20 pmRNSHolding(s) in Company
22nd May 20268:38 amRNSHolding(s) in Company
20th May 20267:00 amRNSAppointment of Non-Executive Director
20th May 20267:00 amRNSAudited Preliminary Results
12th May 20267:00 amRNSNotice of Preliminary Results
30th Apr 20262:47 pmRNSHolding(s) in Company
23rd Apr 202612:25 pmRNSHolding(s) in Company
15th Apr 202612:49 pmRNSAppointment of Executive Director - Replacement
15th Apr 20267:00 amRNSAppointment of Executive Director
1st Apr 20269:00 amRNSHolding(s) in Company
24th Mar 20267:22 amRNSHolding(s) in Company
19th Mar 20261:15 pmRNSHolding(s) in Company
5th Mar 20267:00 amRNSTrading Update
18th Feb 20265:51 pmRNSHolding(s) in Company
13th Feb 202610:21 amRNSBLOCK LISTING SIX MONTHLY RETURN
12th Feb 20264:39 pmRNSHolding(s) in Company
28th Jan 20267:00 amRNS-RBloomsbury to grow Academic sales in Asia
8th Dec 202510:05 amRNSDirector/PDMR Shareholding
3rd Dec 20257:00 amRNSGoogle and Bloomsbury Strategic Collaboration
19th Nov 202511:53 amRNSHolding(s) in Company
23rd Oct 20257:00 amRNSUnaudited Interim Results
8th Oct 20257:00 amRNS-RAuthor Katherine Rundell announces multi-film deal
2nd Oct 20255:22 pmRNSHolding(s) in Company
22nd Sep 20254:20 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSAppointment of Chief Financial & Operating Officer
29th Aug 20253:39 pmRNSDirector/PDMR Shareholding
28th Aug 20254:16 pmRNSDirector/PDMR Shareholding
28th Aug 20253:51 pmRNSDirector/PDMR Shareholding
15th Aug 20259:34 amRNSBLOCK LISTING SIX MONTHLY RETURN
13th Aug 202512:11 pmRNSDirector/PDMR Shareholdings - Correction
12th Aug 20254:29 pmRNSDirector/PDMR Shareholding
11th Aug 202511:08 amRNSDirector/PDMR Shareholding
5th Aug 202511:31 amRNSHolding(s) in Company
1st Aug 20251:14 pmRNSDirector/PDMR Shareholding
31st Jul 202511:10 amRNSDirector/PDMR Shareholding
30th Jul 20253:55 pmRNSHolding(s) in Company
29th Jul 20253:08 pmRNSHolding(s) in Company
28th Jul 20254:39 pmRNSHolding(s) in Company
25th Jul 20253:13 pmRNSHolding(s) in Company
24th Jul 20253:48 pmRNSHolding(s) in Company
17th Jul 20253:46 pmRNSHolding(s) in Company
16th Jul 20253:16 pmRNSResults of the 2025 Annual General Meeting
16th Jul 20257:00 amRNSAGM Trading Update
15th Jul 20254:14 pmRNSHolding(s) in Company
4th Jul 20253:54 pmRNSHolding(s) in Company
2nd Jul 20254:39 pmRNSHolding(s) in Company
13th Jun 20255:33 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.